After a major sell-off in the biotech space last week, the Dow Jones Industrial Average rose 1.5% on Monday amid a flurry of M&A activity in the pharmaceuticals space. As we begin a shortened trading week, Steve Freedman, senior investment strategist at UBS, says investors should expect more volatility ahead, though he remains bullish on the overall markets. He also shares insight on which sectors to focus on and why he favors small-cap stocks, which have less global exposure amid the strengthening dollar. Plus, Freedman comments on Monday morning’s key economic data, including consumer spending and the latest reading on the personal consumption expenditure price index, the Federal Reserve’s preferred inflation gauge.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
